These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
(1)
|
Title of each class of securities to which transaction applies:
|
|
(2)
|
Aggregate number of securities to which transaction applies:
|
|
(3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0‑11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
|
(5)
|
Total fee paid:
|
|
¨
|
Fee paid previously with preliminary materials.
|
|
¨
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0‑11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
(1)
|
Amount Previously Paid:
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
|
(3)
|
Filing Party:
|
|
(4)
|
Date Filed:
|
|
•
|
the election, as directors, of the nominees named in this proxy statement to hold office until the 2020 annual meeting of stockholders or until their successors are duly elected and qualified;
|
|
•
|
a proposal to ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 31, 2020; and
|
|
•
|
FOR the ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending January 31, 2020.
|
|
•
|
notifying the corporate secretary of Domo, Inc., in writing, at the address listed on the front page; or
|
|
•
|
Proposal No. 1
: The election of directors requires a plurality vote of the shares of common stock voted at the meeting. “Plurality” means that the individuals who receive the largest number of votes cast “For” are elected as directors. Any shares not voted “For” a particular nominee (whether as a result of withholding or a broker non-vote) are not counted in such nominee’s favor and have no effect on the election outcome.
|
|
•
|
Proposal No. 2
: The ratification of the appointment of Ernst & Young LLP must receive the affirmative vote of a majority of the shares present in person or by proxy at the meeting and entitled to vote thereon. Abstentions are considered votes cast and thus have the same effect as a vote “Against” the proposal.
|
|
•
|
the 10th day following the day on which public announcement of the date of such meeting is first made.
|
|
Nominees
|
|
Age
|
|
Position
|
|
Joshua G. James
(3)
|
|
45
|
|
Founder, Chief Executive Officer and Chairman
|
|
Fraser Bullock
(2)
|
|
64
|
|
Director
|
|
Carine S. Clark
(2)
|
|
56
|
|
Director
|
|
Daniel Daniel
(1)
|
|
44
|
|
Director
|
|
Dana Evan
(1)
|
|
59
|
|
Director
|
|
Mark Gorenberg
(1)(3)
|
|
64
|
|
Director
|
|
Nehal Raj
(2)
|
|
40
|
|
Director
|
|
(1)
|
Member of the audit committee
|
|
(2)
|
Member of the compensation committee
|
|
(3)
|
Member of the nominating and corporate governance committee
|
|
•
|
approves the hiring, discharging and compensation of our independent registered public accounting firm;
|
|
•
|
oversees the work of our independent registered public accounting firm;
|
|
•
|
approves engagements of the independent registered public accounting firm to render any audit or permissible non-audit services;
|
|
•
|
reviews the qualifications, independence and performance of the independent registered public accounting firm;
|
|
•
|
reviews our consolidated financial statements and review our critical accounting policies and estimates;
|
|
•
|
develops procedures for employees to anonymously submit concerns about questionable accounting or audit matters;
|
|
•
|
reviews the adequacy and effectiveness of our internal controls; and
|
|
•
|
reviews and discusses the scope and results of the audit with the independent registered public accounting firm and review, with management and the independent accountants, our interim and annual operating results.
|
|
•
|
reviews and recommends policies relating to compensation and benefits of our officers and employees;
|
|
•
|
reviews and approves corporate goals and objectives relevant to compensation of our founder and chief executive officer and other senior officers;
|
|
•
|
evaluates the performance of our officers in light of established goals and objectives; recommend compensation of our officers based on its evaluations; and
|
|
•
|
administers the issuance of stock options and other awards under our stock plans.
|
|
•
|
evaluates and makes recommendations regarding the organization and governance of the board of directors and its committees;
|
|
•
|
assesses the performance of members of the board of directors and make recommendations regarding committee and chair assignments;
|
|
•
|
recommends desired qualifications for board of directors membership and conduct searches for potential members of the board of directors; and
|
|
•
|
reviews and makes recommendations with regard to our corporate governance guidelines.
|
|
Name
|
|
Fees Earned or paid in Cash ($)(1)
|
|
Stock Awards ($)(2)
|
|
Total ($)
|
|
Fraser Bullock
|
|
34,688
|
|
410,000
|
|
444,688
|
|
Matthew Cohler(3)
|
|
25,313
|
|
410,000
|
|
435,313
|
|
Dana Evan
|
|
31,250
|
|
410,000
|
|
441,250
|
|
Mark Gorenberg
|
|
21,875
|
|
410,000
|
|
431,875
|
|
Nehal Raj
|
|
—
|
|
—
|
|
—
|
|
Glenn Solomon(3)
|
|
23,438
|
|
410,000
|
|
433,438
|
|
(1)
|
Includes an annual retainer fee and a committee fee or chairperson fee, as applicable, earned quarterly.
|
|
(2)
|
Represents the aggregate grant-date fair value of stock option awards granted. We have computed these amounts in accordance with Financial Accounting Standards Board (“FASB”), Accounting Standards Codification (“ASC”), Topic 718. For a discussion of the assumptions used in calculating the dollar amount recognized for financial statement reporting purposes of the equity awards reported in this column, see the notes to our financial statements included in our annual report on Form 10-K for the fiscal year ended January 31, 2019.
|
|
(3)
|
Mr. Cohler and Mr. Solomon resigned from our board of directors in March 2019.
|
|
•
|
$7,500 retainer per quarter for each non-employee director;
|
|
•
|
$3,750 retainer per quarter for our lead non-employee director (if applicable);
|
|
•
|
$5,000 retainer per quarter for the chair of the audit committee or $1,875 retainer per quarter for each other member of the audit committee;
|
|
•
|
$2,625 retainer per quarter for the chair of the compensation committee or $1,250 retainer per quarter for each other member of the compensation committee; and
|
|
•
|
$1,875 retainer per quarter for the chair of the nominating and corporate governance committee or $750 retainer per quarter for each other member of the nominating and corporate governance committee.
|
|
|
|
Year Ended January 31,
|
||||||
|
Fee Category
|
|
2019
|
|
2018
|
||||
|
Audit fees(1)
|
|
$
|
1,379,220
|
|
|
|
$1,871,530
|
|
|
Audit-related fees(2)
|
|
—
|
|
|
—
|
|
||
|
Tax fees(3)
|
|
—
|
|
|
—
|
|
||
|
All other fees(4)
|
|
5,085
|
|
|
1,750
|
|
||
|
Total fees
|
|
$
|
1,384,305
|
|
|
$
|
1,873,280
|
|
|
(1)
|
Audit fees consist of fees for professional services provided in connection with the audit of our annual consolidated financial statements, review of our quarterly consolidated financial statements and our public offerings.
|
|
(2)
|
Audit-related fees consist of fees for professional services for assurance and related services that are reasonably related to the performance of the audit or review of our consolidated financial statements and are not reported under “Audit fees.”
|
|
(3)
|
Tax fees consist of fees for professional services for tax compliance, tax advice and tax planning.
|
|
(4)
|
All other fees include any fees billed that are not audit or audit related. These fees related to an accounting research tool
.
|
|
Name
|
|
Age
|
|
Position
|
|
Joshua G. James
|
|
45
|
|
Founder, Chief Executive Officer and Chairman of the Board
|
|
Bruce Felt
|
|
61
|
|
Chief Financial Officer
|
|
Catherine Wong
|
|
43
|
|
Chief Product Officer and Executive Vice President of Engineering
|
|
Name and Principal Position
|
|
Year
|
|
Salary ($)
|
|
Bonus (1)
|
|
Stock Awards ($)(2)
|
|
Non-Equity Incentive Plan Compensation ($)(3)
|
|
All Other Compensation ($)(4)
|
|
Total ($)
|
|
Joshua G. James
|
|
2019
|
|
400,449
|
|
—
|
|
—
|
|
317,910
|
|
15,111
|
|
733,470
|
|
Founder, Chief Executive Officer and Director
|
|
2018
|
|
350,000
|
|
—
|
|
—
|
|
—
|
|
12,659
|
|
362,659
|
|
Bruce Felt
|
|
2019
|
|
377,244
|
|
—
|
|
807,892
|
|
198,694
|
|
33,373
|
|
1,417,203
|
|
Chief Financial Officer
|
|
2018
|
|
350,000
|
|
100,000
|
|
2,340,000
|
|
—
|
|
23,809
|
|
2,813,809
|
|
Catherine Wong
|
|
2019
|
|
354,038
|
|
—
|
|
495,900
|
|
370,895
|
|
13,819
|
|
1,234,652
|
|
Chief Product Officer and Executive Vice President of Engineering
|
|
2018
|
|
350,000
|
|
450,000
|
|
1,950,000
|
|
—
|
|
11,550
|
|
2,761,550
|
|
(1)
|
Amounts represent the payment of a discretionary bonus and, for Ms. Wong, additional one-time discretionary bonuses totaling $350,000 in recognition of her contributions to the Company during the fiscal year ended January 31, 2018.
|
|
(2)
|
The amounts reported in this column represent the aggregate grant date fair value of the restricted stock units, or RSUs, granted under our 2011 Equity Incentive Plan or 2018 Equity Incentive Plan to our named executive officers in each of the fiscal years ended January 31, 2019 and 2018 as computed in accordance with FASB ASC Topic 718. The assumptions used in calculating the dollar amount recognized for financial statement reporting purposes of the equity awards reported in this column are set forth in the notes to our financial statements included in our annual report on Form 10-K for the fiscal year ended January 31, 2019. Note that the amounts reported in this column reflect the accounting value for these equity awards and do not correspond to the actual economic value that may be received by our named executive officers from the equity awards.
|
|
(3)
|
The amounts reported in this column represent amounts earned and payable under the Executive Incentive Compensation Plan, or the Bonus Plan, for the fiscal year ended January 31, 2019, all of which were paid during fiscal year ending January 31, 2020, except for $291,667 paid to Ms. Wong during the fiscal year ended January 31, 2019.
|
|
(4)
|
Reflects matching contributions made by us under our 401(k) plan. For Mr. Felt, also reflects spousal travel, including gross ups of $5,574 in the year ended January 31, 2019 and $3,899 in the fiscal year ended January 31, 2018 for the related taxes.
|
|
•
|
a lump-sum payment equal to 12 months (or 18 months in the case of Mr. James) of the named executive officer’s annual base salary as in effect immediately prior to such termination (or if such termination is due to a resignation for good reason based on a material reduction in base salary, then as in effect immediately prior to the reduction);
|
|
•
|
in the case of Mr. Felt only, a lump-sum payment equal to 100% of his target annual bonus as in effect for the fiscal year in which such termination occurs; and
|
|
•
|
payment of premiums for coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended, or COBRA, for the named executive officer and the named executive officer’s eligible dependents, if any, for up to 12 months (or 18 months in the case of Mr. James), or taxable monthly payments for the equivalent period in the event payment of the COBRA premiums would violate or be subject to an excise tax under applicable law.
|
|
•
|
a lump-sum payment equal to 12 months (or 18 months in the case of Mr. James) of the executive’s annual base salary as in effect immediately prior to such termination (or if such termination is due to a resignation for good reason based on a material reduction in base salary, then as in effect immediately prior to the reduction) or if greater, at the level in effect immediately prior to the change in control);
|
|
•
|
a lump-sum payment equal to 100% (or 150% in the case of Mr. James) of the named executive officer’s target annual bonus as in effect for the fiscal year in which such termination occurs;
|
|
•
|
payment of premiums for coverage under COBRA for the named executive officer and the named executive officer’s eligible dependents, if any, for up to 12 months (or 18 months in the case of Mr. James), or taxable monthly payments for the equivalent period in the event payment of the COBRA premiums would violate or be subject to an excise tax under applicable law; and
|
|
•
|
100% accelerated vesting and exercisability of all outstanding equity awards and, in the case of an equity award with performance-based vesting, all performance goals and other vesting criteria generally will be deemed achieved at 100% of target levels.
|
|
|
|
|
|
Number of Securities Underlying Unexercised Options
|
|
Stock Awards
|
||||||||
|
Name
|
|
Vesting Commencement Date
|
|
Exercisable (#)
|
|
Unexercisable (#)
|
|
Option Exercise Prices ($)
|
|
Option Expiration Date
|
|
Number of Shares that Have Not Vested(#)(2)
|
|
Market Value of Shares that Have Not Vested ($)(2)
|
|
Joshua G. James
|
|
9/4/2014
|
|
616,921
|
|
—
|
|
25.50
|
|
9/3/2024
|
|
|
|
|
|
Bruce Felt
|
|
8/18/2014
|
|
154,230
|
|
—
|
|
25.50
|
|
9/3/2024
|
|
|
|
|
|
|
|
1/31/2018
|
|
|
|
|
|
|
|
|
|
100,000
|
|
2,700,000
|
|
|
|
02/21/2018
|
|
|
|
|
|
|
|
|
|
13,333
|
|
359,991
|
|
|
|
11/04/2018
|
|
|
|
|
|
|
|
|
|
30,000
|
|
810,000
|
|
Catherine Wong
|
|
9/23/2013
|
|
45,089
|
|
—
|
|
8.40
|
|
10/7/2023
|
|
|
|
|
|
|
|
9/4/2014
|
|
26,666
|
|
—
|
|
25.50
|
|
9/3/2024
|
|
|
|
|
|
|
|
12/13/2014
|
|
666
|
|
—
|
|
25.50
|
|
1/28/2025
|
|
|
|
|
|
|
|
11/16/2015
|
|
31,666
|
|
—
|
|
27.60
|
|
9/30/2026
|
|
|
|
|
|
|
|
1/31/2018
|
|
|
|
|
|
|
|
|
|
57,292
|
|
1,546,884
|
|
|
|
11/04/2018
|
|
|
|
|
|
|
|
|
|
30,000
|
|
810,000
|
|
(1)
|
Stock option vests over four years, with 25% vesting on the first anniversary of the vesting commencement date and the remainder vesting monthly over the following 36 months, subject to continued service.
|
|
(2)
|
This column represents the market value of the shares underlying the RSUs as of December 31, 2017, based on the closing price of our Class B common stock of $27.00 per share on January 31, 2019. The RSUs are scheduled to vest as to 25% of the RSUs on the one-year anniversary of the vesting commencement date, and 1/16th of the RSUs quarterly thereafter, provided that in no event will any RSUs vest before the earlier of (a) immediately prior to a change of control (as defined in our 2011 Equity Incentive Plan) and (b) the first scheduled vesting date occurring more than 180 days after the date of this prospectus. The vesting of RSUs on any such vesting dates is subject to the named executive officer’s continued service with us through such date.
|
|
Plan Category
|
|
(a) Number of
Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights |
|
(b) Weighted
Average Exercise Price of Outstanding Options, Warrants and Rights (1) |
|
(c) Number of Securities
Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in Column (a))(2) |
||||
|
Equity compensation plans approved by stockholders(3)
|
|
4,184,461
|
|
|
$
|
23.20
|
|
|
5,300,380
|
|
|
Equity compensation plans not approved by stockholders
|
|
—
|
|
|
|
—
|
|
|
—
|
|
|
Total
|
|
4,184,461
|
|
|
|
|
|
5,300,380
|
|
|
|
(1)
|
The weighted average exercise price is calculated based solely on outstanding stock options. It does not take into account the shares of our Class B common stock underlying restricted stock units, which have no exercise price.
|
|
(2)
|
Includes 4,466,868 shares available for issuance under our 2018 Plan and 833,512 shares available for issuance under our 2018 ESPP.
|
|
(3)
|
Includes the following plans: the 2011 Equity Incentive Plan, the 2018 Plan and the 2018 ESPP. Our 2018 Plan provides that on February 1 of each fiscal year commencing in 2019, the number of shares authorized for issuance under the 2018 Plan is automatically increased by a number equal to the least of (subject to adjustment upon changes in our capitalization as provided in the 2018 Plan) (a) 5% of the outstanding shares of Class A and Class B common stock as of the last day of the immediately preceding fiscal year, (b) 3,500,000 shares and (c) such number of shares determined by the board of directors. Our 2018 ESPP provides that on February 1 of each fiscal year commencing in 2019, the number of shares authorized for issuance under the 2018 ESPP is automatically increased by a number equal to the least of (a) 1.5% of the outstanding shares of Class A and Class B common stock on the first day of each year, (b) 1,050,000 shares of Class B common stock and (c) an amount determined by the board of directors.
|
|
|
|
Class A
|
|
Class B
|
|
|
|
% of Total Voting Power
|
||
|
Name
|
|
Shares
|
|
%
|
|
Shares
|
|
%
|
|
|
|
5% Stockholders
|
|
|
|
|
|
|
|
|
|
|
|
Cocolalla, LLC(2)
|
|
3,263,659
|
|
100%
|
|
—
|
|
—%
|
|
84.4%
|
|
BlackRock, Inc.(3)
|
|
—
|
|
—
|
|
4,381,597
|
|
18.2%
|
|
2.8%
|
|
Entities affiliated with Sylebra(4)
|
|
—
|
|
—
|
|
2,388,292
|
|
9.9%
|
|
1.5%
|
|
Entities affiliated with Institutional Venture Partners(5)
|
|
—
|
|
—
|
|
1,609,537
|
|
6.7%
|
|
1.0%
|
|
Entities affiliated with Benchmark Capital (6)
|
|
—
|
|
—
|
|
1,492,752
|
|
6.2%
|
|
1.0%
|
|
ArrowMark Colorado Holdings, LLC(7)
|
|
—
|
|
—
|
|
1,468,227
|
|
6.1%
|
|
1.0%
|
|
Named Executive Officers and Directors
|
|
|
|
|
|
|
|
|
|
|
|
Joshua G. James(8)
|
|
3,263,659
|
|
100%
|
|
719,064
|
|
2.9%
|
|
84.9%
|
|
Bruce Felt(9)
|
|
—
|
|
—
|
|
182,473
|
|
*
|
|
*
|
|
Catherine Wong(10)
|
|
—
|
|
—
|
|
125,408
|
|
*
|
|
*
|
|
Fraser Bullock(11)
|
|
—
|
|
—
|
|
106,428
|
|
*
|
|
*
|
|
Matthew Cohler(12)
|
|
—
|
|
—
|
|
1,492,752
|
|
6.2
|
|
1.0
|
|
Dana Evan
|
|
—
|
|
—
|
|
—
|
|
—
|
|
*
|
|
Mark Gorenberg(13)
|
|
—
|
|
—
|
|
111,389
|
|
*
|
|
*
|
|
Glenn Solomon(14)
|
|
—
|
|
—
|
|
—
|
|
—
|
|
*
|
|
Nehal Raj
|
|
—
|
|
—
|
|
—
|
|
—
|
|
*
|
|
Carine Clark(15)
|
|
—
|
|
—
|
|
—
|
|
—
|
|
*
|
|
Daniel Daniel(16)
|
|
—
|
|
—
|
|
—
|
|
—
|
|
*
|
|
All Executive Officers & Directors as a Group (11 persons)(17)
|
|
3,263,659
|
|
100%
|
|
2,737,514
|
|
11.0%
|
|
88.2%
|
|
*
|
Represents beneficial ownership or voting power of less than 1%.
|
|
(1)
|
Percentage total voting power represents voting power with respect to all outstanding shares of our Class A common stock and Class B common stock, voting as a single class. Each holder of Class A common stock shall be entitled to 40 votes per share of Class A common stock and each holder of Class B common stock shall be entitled to one vote per share of Class B common stock. Holders of Class A common stock and Class B common stock will vote together as a single class on all matters (including the election of directors) submitted to a vote of stockholders, unless otherwise required by law or our amended and restated certificate of incorporation. The Class A common stock is convertible at any time by the holder into shares of Class B common stock on a share-for-share basis.
|
|
(2)
|
Joshua G. James, our founder, chief executive officer and a director, is the managing member of Cocolalla, LLC, and he has sole power to vote and dispose of the shares, which are directly owned by Cocolalla, LLC. All of the shares directly owned by Cocolalla, LLC have been pledged as a security to a financial institution.
|
|
(3)
|
According to a Schedule 13G/A filed with the SEC on February 11, 2019, which reports sole dispositive power and sole voting power over 4,381,597 shares of our Class B common stock.
|
|
(4)
|
According to a Schedule 13G filed with the SEC on January 7, 2019, Sylebra HK Company Limited (“Sylebra HK”) may be deemed to beneficially own the shares of our Class B common stock by virtue of its position as the investment advisor to Sylebra Capital Management (“Sylebra Cayman”) in relation to Sylebra Capital Partners Fund, Ltd. and other advisory clients. Sylebra Cayman serves as the investment manager to Sylebra Capital Partners Master Fund Ltd and is the parent of Sylebra HK. Daniel Patrick Gibson owns 100% of the shares of Sylebra HK and Sylebra Cayman. In such capacities, Sylebra HK, Sylebra Cayman and Mr. Gibson may be deemed to share voting and dispositive power over the shares held for Sylebra Capital Partners Master Fund Ltd and other advisory clients.
|
|
(5)
|
According to a Schedule 13G filed with the SEC on February 14, 2019, the shares consist of (a) 1,367,597 shares of our Class B common stock held by Institutional Venture Partners XIII, L.P. (“IVP XIII”), (b) 240,663 shares of our Class B common stock held by Institutional Venture Partners XV, L.P. (“IVP XV”) and (c) 1,280 shares of our Class B common stock held by Institutional Venture Partners XV Executive Fund, L.P. (“IVP Executive Fund”). Institutional Venture Management XIII, LLC (“IVM XIII”) serves as the sole general partner of IVP XIII and has sole voting and investment control over the shares owned by IVP XIII and may be deemed to beneficially own the shares held by IVP
|
|
(6)
|
According to a Schedule 13G/A filed with the SEC on February 11, 2019, the shares consist of (a) 1,186,373 shares of our Class B common stock of our Class B common stock held by Benchmark Capital Partners VII, L.P. (“BCP VII”), (b) 131,757 shares of our Class B common stock held by Benchmark Founders’ Fund VII, L.P. (“BFF VII”) and (c) 174,622 shares of our Class B common stock are held by Benchmark Founders’ Fund VII-B, L.P. (“BFF VII-B”). Benchmark Capital Management Co. VII, L.L.C. (“BCMC VII”) is the general partner of BCP VII, BFF VII and BFF VII-B and may be deemed to have sole power to vote the shares held by BCP VII, BFF VII and BFF VII-B. Matthew Cohler, Bruce Dunlevie, Peter Fenton, J. William Gurley, Kevin Harley, Mitchell Lasky, Steven Spurlock and Eric Vishria are members of BCMC VII and may be deemed to have shared power to vote the shares held by BCP VII, BFF VII and BFF VII-B. The address for Benchmark Capital Partners is 2965 Woodside Road, Woodside, CA 94062.
|
|
(7)
|
According to a Schedule 13G filed with the SEC on February 14, 2019, which reports sole dispositive power and sole voting power over 1,468,227 shares of our Class B common stock. The address for ArrowMark Colorado Holdings, LLC is 100 Fillmore Street, Suite 325, Denver, CO 80206.
|
|
(8)
|
Consists of (a) 3,263,659 shares of Class A common stock held of record by Cocolalla, LLC, (b) 100,000 shares of our Class B common stock held of record by Mr. James, (c) 2,143 shares of our Class B common stock held of record by Marina James, Mr. James’ wife and (d) options to purchase 616,921 shares of Class B common stock held of record by Mr. James that are exercisable within 60 days of April 8, 2019. 3,263,659 shares of Class A common stock held by Cocolalla, LLC and 100,000 shares of Class B common stock held by Mr. James have been pledged as a security to a financial institution.
|
|
(9)
|
Consists of (a) 28,243 shares of our Class B common stock held by Mr. Felt and (b) options to purchase 154,230 shares of Class B common stock that are exercisable within 60 days of April 8, 2019.
|
|
(10)
|
Consists of (a) 17,988 shares of our Class B common stock held by Ms. Wong and (b) options to purchase 107,420 shares of our Class B common stock that are exercisable within 60 days of April 8, 2019.
|
|
(11)
|
Consists of (a) 97,762 shares of Class B common stock held of record by Bullock Family 101 Trust and (b) 8,666 shares of Class B common stock held of record by Bullock Family 2003 Gift Trust.
|
|
(12)
|
Consists of 1,492,752 shares of Class B common stock held by BCP VII, BFF VII and BFF VII-B. Please see footnote 6 regarding Mr. Cohler’s voting and investment power over the shares held by BCP VII, BFF VII and BFF VII-B. Mr. Cohler resigned from our board of directors in March 2019.
|
|
(13)
|
Consists of (a) 93,934 shares of Class B common stock held by Zetta Venture Partners I, L.P. and (b) options to purchase 17,455 shares of our Class B common stock that are exercisable within 60 days of April 8, 2019. Zetta Equity Partners I, LLC is the general partner of Zetta Venture Partners I, L.P. Mr. Gorenberg and Ashley Fontana are the managing directors of Zetta Equity Partners I, LLC and share voting and investment control over the shares held by Zetta Venture Partners I, L.P.
|
|
(14)
|
Mr. Solomon resigned from our board of directors in March 2019.
|
|
(15)
|
Ms. Clark did not join our board of directors until March 2019.
|
|
(16)
|
Mr. Daniel did not join our board of directors until April 2019.
|
|
(17)
|
Includes 896,026 shares of Class B common stock issuable upon exercise of options that are exercisable within 60 days of April 8, 2019.
|
|
•
|
transactions involving the purchase or sale of products or services in the ordinary course of business, not exceeding $20,000;
|
|
•
|
transactions where a related party’s interest derives solely from his or her service as a director of another entity that is a party to the transaction;
|
|
•
|
transactions where a related party’s interest derives solely from his or her ownership of less than 10% of the equity interest in another entity that is a party to the transaction; and
|
|
•
|
transactions where a related party’s interest derives solely from his or her ownership of a class of our equity securities and all holders of that class received the same benefit on a pro rata basis.
|
|
•
|
the benefits and perceived benefits to us;
|
|
•
|
the materiality and character of the related party’s direct and indirect interest;
|
|
•
|
the availability of other sources for comparable products or services;
|
|
•
|
the terms of the transaction; and
|
|
•
|
the terms available to unrelated third parties under the same or similar circumstances.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|